Stocks Congress trades
Every security that appears in a disclosure, ranked by activity. “Members” is the number of distinct people who traded it — a better measure of how widely held a name is than raw transaction count, which one prolific filer can dominate.
SectorAllIndustrialsFinancialsInformation TechnologyHealth CareConsumer DiscretionaryMaterialsReal EstateCommunication ServicesEnergyUtilitiesConsumer StaplesOther
Top 100 in Health Care by trades
| # | Security | Members | Trades | 90 days | Est. volume | Party split | Last trade |
|---|---|---|---|---|---|---|---|
| 1 |  JNJJNJ Johnson & Johnson | 97 | 374240B/134S | +7% | ~$7.8M | 36D · 61R | Jun 29, 2026 |
| 2 |  PFEPFE Pfizer Inc. | 82 | 337165B/172S | -1% | ~$4.8M | 35D · 47R | Jun 8, 2026 |
| 3 |  MRKMRK Merck & Company, Inc. Common Stock | 71 | 262152B/109S | +8% | ~$10.7M | 27D · 44R | Mar 27, 2026 |
| 4 |  ABBVABBV AbbVie Inc | 65 | 238143B/91S | +15% | ~$22.6M | 22D · 43R | May 5, 2026 |
| 5 |  BMYBMY Bristol-Myers Squibb Company | 56 | 235127B/104S | +9% | ~$41.5M | 22D · 34R | May 7, 2026 |
| 6 |  MDTMDT Medtronic plc. Ordinary Shares | 58 | 194102B/80S | +1% | ~$4.5M | 29D · 29R | May 15, 2026 |
| 7 |  LLYLLY Eli Lilly and Company Common Stock | 47 | 17190B/80S | +29% | ~$9.1M | 20D · 26R · 1I | Jul 10, 2026 |
| 8 |  ZTSZTS Zoetis Inc. Class A Common Stock | 36 | 15097B/53S | -38% | ~$8.6M | 14D · 22R | Jun 16, 2026 |
| 9 |  ABTABT Abbott Laboratories Common Stock | 51 | 14589B/54S | +6% | ~$8.2M | 19D · 32R | Jul 8, 2026 |
| 10 |  MMMMMM 3M Company | 44 | 13583B/52S | +27% | ~$39.3M | 23D · 20R · 1I | Apr 28, 2026 |
| 11 |  AMGNAMGN Amgen Inc | 39 | 12578B/47S | +18% | ~$2.1M | 10D · 29R | Jun 5, 2026 |
| 12 |  GILDGILD Gilead Sciences, Inc. - Common Stock | 37 | 11986B/33S | -4% | ~$1.5M | 13D · 23R · 1I | May 6, 2026 |
| 13 |  NVSNVS Novartis Ag | 24 | 10762B/45S | +2% | ~$2.0M | 9D · 14R · 1I | Mar 31, 2026 |
| 14 |  BSXBSX Boston Scientific Corporation | 19 | 10260B/42S | -21% | ~$963K | 7D · 12R | Jun 5, 2026 |
| 15 |  BIIBBIIB Biogen Inc | 29 | 9866B/32S | +13% | ~$1.3M | 14D · 15R | Jun 5, 2026 |
| 16 |  BAXBAX Baxter International Inc. (NYSE) | 19 | 9462B/32S | +64% | ~$1.4M | 6D · 13R | Mar 23, 2026 |
| 17 |  ISRGISRG Intuitive Surgical, Inc. - Common Stock | 23 | 9353B/40S | -18% | ~$1.1M | 10D · 13R | Mar 27, 2026 |
| 18 |  SYKSYK Stryker Corporation | 26 | 9232B/60S | +3% | ~$1.9M | 13D · 13R | Jun 2, 2026 |
| 19 |  REGNREGN Regeneron Pharmaceuticals, Inc. - Common Stock | 23 | 8448B/36S | +2% | ~$795K | 10D · 13R | May 15, 2026 |
| 20 |  HCAHCA HCA Healthcare, Inc | 18 | 6637B/29S | -12% | ~$3.7M | 9D · 9R | Jun 17, 2026 |
| 21 |  NVONVO Novo Nordisk A/S Common Stock | 18 | 6140B/19S | +29% | ~$2.8M | 5D · 13R | Mar 30, 2026 |
| 22 |  BDXBDX Becton, Dickinson and Company | 20 | 6038B/22S | +13% | ~$652K | 6D · 14R | May 21, 2026 |
| 23 |  ILMNILMN Illumina, Inc | 13 | 5832B/26S | +53% | ~$636K | 7D · 6R | Feb 10, 2026 |
| 24 |  AZNAZN AstraZeneca PLC - American Depositary Shares | 24 | 4932B/16S | -18% | ~$822K | 11D · 13R | Mar 31, 2026 |
| 25 |  VTRSVTRS Viatris Inc | 18 | 4919B/27S | +22% | ~$1.9M | 9D · 9R | Nov 18, 2025 |
| 26 |  IDXXIDXX IDEXX Laboratories, Inc. - Common Stock | 8 | 4732B/13S | +4% | ~$1.2M | 2D · 6R | Jan 13, 2026 |
| 27 |  TECHTECH Bio-Techne Corp - Common Stock | 9 | 4624B/18S | +39% | ~$734K | 4D · 5R | Apr 8, 2026 |
| 28 |  GSKGSK GSK plc American Depositary Shares | 16 | 4429B/15S | -3% | ~$959K | 4D · 12R | Oct 31, 2025 |
| 29 |  VRTXVRTX Vertex Pharmaceuticals Incorporated | 19 | 4421B/23S | +11% | ~$499K | 8D · 11R | Mar 27, 2026 |
| 30 |  ALGNALGN Align Technology, Inc | 13 | 4326B/16S | +1% | ~$3.4M | 6D · 7R | Sep 11, 2025 |
| 31 |  EWEW Edwards Lifesciences Corporation | 20 | 4325B/18S | +12% | ~$509K | 7D · 13R | Mar 27, 2026 |
| 32 |  XRAYXRAY Dentsply Sirona Inc | 9 | 4130B/10S | +4% | ~$769K | 4D · 4R · 1I | Jan 8, 2025 |
| 33 |  WSTWST West Pharmaceutical Services, Inc | 14 | 4026B/12S | +41% | ~$53.5M | 6D · 8R | Jul 22, 2025 |
| 34 |  LHLH Labcorp Holdings Inc. Common Stock | 12 | 3825B/13S | +20% | ~$679K | 4D · 8R | Mar 27, 2026 |
| 35 |  TFXTFX Teleflex Incorporated | 11 | 3820B/16S | +13% | ~$1.6M | 3D · 8R | Jul 22, 2025 |
| 36 |  DXCMDXCM DEXCOM INC | 11 | 3722B/15S | +35% | ~$1.7M | 5D · 6R | May 7, 2026 |
| 37 |  IQVIQV IQVIA Holdings, Inc | 10 | 3715B/22S | +40% | ~$702K | 6D · 4R | Mar 16, 2026 |
| 38 |  REVBREVB Revere Bank | 1 | 360B/36S | -9% | ~$435K | 0D · 1R | Jul 31, 2019 |
| 39 |  WATWAT Waters Corporation Common Stock | 13 | 3521B/12S | +37% | ~$1.3M | 5D · 7R · 1I | Mar 18, 2026 |
| 40 |  STESTE STERIS plc | 10 | 3118B/12S | +8% | ~$1.4M | 4D · 6R | Jul 31, 2026 |
| 41 |  AA Agilent Technologies, Inc. Common Stock | 13 | 3015B/15S | +28% | ~$430K | 5D · 8R | Sep 23, 2025 |
| 42 |  DGXDGX Quest Diagnostics Incorporated Common Stock | 13 | 3020B/10S | +22% | ~$289K | 7D · 6R | Mar 30, 2026 |
| 43 |  SNYSNY Sanofi - American Depositary Shares | 17 | 3017B/13S | -6% | ~$697K | 4D · 13R | Mar 30, 2026 |
| 44 |  ICUIICUI ICU MED INCORPORATED | 4 | 2911B/12S | +43% | ~$257K | 2D · 2R | May 6, 2025 |
| 45 |  ZBHZBH Zimmer Biomet Holdings, Inc | 11 | 2913B/16S | +7% | ~$571K | 6D · 5R | Mar 27, 2026 |
| 46 |  PRGOPRGO PERRIGO CO PLC COM STK | 7 | 2622B/4S | +22% | ~$9.6M | 1D · 6R | Oct 11, 2018 |
| 47 |  RMDRMD ResMed Inc. Common Stock | 8 | 269B/17S | -5% | ~$809K | 4D · 4R | Mar 27, 2026 |
| 48 |  MRNAMRNA Moderna, Inc | 6 | 258B/17S | +16% | ~$475K | 4D · 2R | Apr 8, 2025 |
| 49 |  CRLCRL Charles River Laboratories International, Inc | 9 | 2011B/9S | +55% | ~$234K | 5D · 4R | May 15, 2025 |
| 50 |  CYRXCYRX CryoPort, Inc | 3 | 2010B/10S | +83% | ~$160K | 3D · 0R | Sep 15, 2023 |
| 51 |  EDITEDIT Editas Medicine, Inc | 5 | 2012B/8S | +16% | ~$234K | 3D · 2R | Apr 10, 2023 |
| 52 |  ELANELAN Elanco Animal Health Incorporated | 9 | 199B/9S | -8% | ~$226K | 6D · 3R | Sep 23, 2025 |
| 53 |  SRPTSRPT Sarepta Therapeutics, Inc | 4 | 1912B/7S | -23% | ~$226K | 3D · 1R | Apr 14, 2025 |
| 54 |  TEVATEVA Teva Pharmaceutical Industries Limited American Depositary Shares | 11 | 1810B/8S | +17% | ~$401K | 4D · 6R · 1I | Mar 30, 2026 |
| 55 |  HUMAHUMA Humacyte, Inc. - Common Stock | 1 | 1711B/6S | +20% | ~$350K | 0D · 1R | May 3, 2024 |
| 56 |  MEDPMEDP Medpace Holdings, Inc. - Common Stock | 6 | 176B/11S | +23% | ~$161K | 2D · 4R | May 15, 2026 |
| 57 |  COOCOO COOPER COS INC/THE CMN | 6 | 1611B/4S | +4% | ~$275K | 4D · 2R | Jun 5, 2026 |
| 58 |  NTLANTLA Intellia Therapeutics, Inc | 3 | 168B/8S | -7% | ~$202K | 2D · 1R | Aug 25, 2023 |
| 59 |  BIOBIO Bio-Rad Laboratories, Inc. Class A | 7 | 157B/8S | +26% | ~$3.1M | 3D · 4R | Sep 8, 2023 |
| 60 |  BRKRBRKR Bruker Corporation | 4 | 1511B/3S | +48% | ~$862K | 3D · 1R | Apr 17, 2023 |
| 61 |  FMSFMS Fresenius Medical Care Ag | 5 | 155B/10S | +11% | ~$477K | 3D · 2R | Jul 10, 2023 |
| 62 |  GMEDGMED Globus Medical, Inc. Class A | 8 | 156B/9S | -4% | ~$145K | 4D · 4R | Mar 3, 2026 |
| 63 |  MTDMTD Mettler-Toledo International, Inc. Common Stock | 7 | 159B/6S | +13% | ~$145K | 1D · 6R | Dec 8, 2025 |
| 64 |  SNNSNN Smith & Nephew SNATS, Inc | 5 | 1510B/5S | -5% | ~$334K | 1D · 4R | Mar 30, 2026 |
| 65 |  VCYTVCYT Veracyte, Inc | 3 | 158B/7S | +47% | ~$120K | 3D · 0R | Mar 3, 2026 |
| 66 |  AHCOAHCO AdaptHealth Corp. - Class A | 2 | 149B/5S | -52% | ~$346K | 1D · 1R | Apr 6, 2023 |
| 67 |  CDNACDNA CareDx, Inc | 2 | 146B/8S | +169% | ~$186K | 2D · 0R | Mar 6, 2023 |
| 68 |  NBIXNBIX NEUROCRINE BIOSCIENCES INC | 2 | 1413B/1S | +24% | ~$112K | 0D · 2R | Jun 17, 2025 |
| 69 |  PODDPODD Insulet Corporation | 3 | 142B/12S | -33% | ~$1.6M | 2D · 1R | May 7, 2026 |
| 70 |  ALCALC Alcon Inc. Ordinary Shares | 8 | 137B/6S | -4% | ~$296K | 5D · 3R | Mar 30, 2026 |
| 71 |  DVADVA DaVita Inc. Common Stock | 6 | 136B/7S | +20% | ~$104K | 1D · 5R | Mar 27, 2026 |
| 72 |  GMABGMAB Genmab A/S - American Depositary Shares | 4 | 138B/5S | +16% | ~$171K | 3D · 1R | Mar 30, 2026 |
| 73 |  ALNYALNY Alnylam Pharmaceuticals, Inc | 4 | 125B/7S | -34% | ~$571K | 2D · 2R | May 12, 2025 |
| 74 |  HAEHAE Haemonetics Corporation | 3 | 126B/6S | +56% | ~$96K | 3D · 0R | May 7, 2021 |
| 75 |  HCSGHCSG Healthcare Services Group, Inc | 5 | 127B/5S | +20% | ~$522K | 1D · 4R | Apr 30, 2020 |
| 76 |  PCRXPCRX Pacira BioSciences, Inc | 2 | 1212B/0S | +11% | ~$194K | 1D · 1R | May 6, 2021 |
| 77 |  RGCRGC REGAL ENTERTAINMENT GROUP CLASS A | 5 | 129B/3S | -79% | ~$1.6M | 2D · 3R | Jun 14, 2024 |
| 78 |  RVTYRVTY Revvity, Inc. Common Stock | 4 | 129B/3S | +31% | ~$145K | 2D · 2R | May 4, 2026 |
| 79 |  AVTRAVTR Avantor, Inc. Common Stock | 6 | 112B/9S | +73% | ~$88K | 4D · 2R | Aug 13, 2025 |
| 80 |  IARTIART Integra LifeSciences Holdings Corporation | 4 | 114B/7S | +83% | ~$88K | 2D · 2R | Jun 18, 2024 |
| 81 |  INCYINCY Incyte Corporation | 8 | 117B/4S | +28% | ~$455K | 5D · 3R | May 15, 2025 |
| 82 |  JAZZJAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 6 | 117B/4S | +36% | ~$162K | 2D · 4R | Jul 12, 2023 |
| 83 |  PHGPHG KONINKLIJKE PHILIPS NV | 4 | 1110B/1S | +1% | ~$480K | 2D · 2R | Feb 12, 2024 |
| 84 |  ANIKANIK Anika Therapeutics Inc | 2 | 107B/3S | +48% | ~$172K | 1D · 1R | Mar 2, 2020 |
| 85 |  CHECHE Chemed Corp | 6 | 103B/7S | +47% | ~$147K | 2D · 4R | Jun 24, 2025 |
| 86 |  HALOHALO Halozyme Therapeutics, Inc | 4 | 104B/6S | +59% | ~$847K | 4D · 0R | Mar 9, 2026 |
| 87 |  INSMINSM Insmed Incorporated - Common Stock | 2 | 102B/8S | -20% | ~$80K | 2D · 0R | Jun 10, 2026 |
| 88 |  TDOCTDOC Teladoc Health, Inc | 2 | 104B/6S | +30% | ~$730K | 2D · 0R | Nov 26, 2021 |
| 89 |  BMRNBMRN BioMarin Pharmaceutical Inc | 4 | 94B/5S | +13% | ~$72K | 2D · 2R | Mar 6, 2023 |
| 90 |  GEHCGEHC GE HealthCare Technologies Inc. - Common Stock | 6 | 94B/4S | +1% | ~$72K | 1D · 5R | Mar 27, 2026 |
| 91 |  PBHPBH PRESTIGE BRANDS HLDGS INCORPORATED | 2 | 96B/2S | -7% | ~$188K | 0D · 2R | Aug 20, 2018 |
| 92 |  SUPNSUPN Supernus Pharmaceuticals, Inc | 2 | 97B/2S | -8% | ~$72K | 2D · 0R | Mar 3, 2026 |
| 93 |  TAKTAK Takeda Pharmaceutical Company Limited American Depositary Shares | 5 | 96B/3S | -6% | ~$146K | 1D · 4R | Aug 29, 2023 |
| 94 |  THCTHC Tenet Healthcare Corporation Common Stock | 3 | 94B/5S | +39% | ~$121K | 1D · 2R | Apr 20, 2026 |
| 95 |  BNTXBNTX BioNTech SE - American Depositary Shares | 2 | 84B/4S | +5% | ~$64K | 2D · 0R | Aug 7, 2025 |
| 96 |  EHCEHC Encompass Health Corporation | 2 | 84B/4S | +30% | ~$64K | 1D · 1R | Oct 31, 2025 |
| 97 |  ICLRICLR ICON plc - Ordinary Shares | 4 | 83B/5S | +49% | ~$398K | 0D · 4R | Mar 5, 2026 |
| 98 |  PCVXPCVX Vaxcyte, Inc. - Common Stock | 3 | 86B/2S | +0% | ~$89K | 1D · 2R | May 13, 2026 |
| 99 |  SOLVSOLV Solventum Corporation Common Stock | 7 | 83B/5S | +27% | ~$89K | 3D · 4R | Mar 27, 2026 |
| 100 |  BBIOBBIO BridgeBio Pharma, Inc. - Common Stock | 1 | 77B/0S | +14% | ~$56K | 1D · 0R | May 11, 2026 |
Sector comes from the company's SIC code in its SEC filings, mapped to a GICS-style grouping — an approximation, not GICS itself. Funds and ETFs have no SIC because they are not operating companies, so they are grouped separately rather than left unclassified. Volume uses bracket midpoints; exact amounts are never disclosed.